The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Adiponectin Levels and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis
Abstract
CONTEXT: The association of obesity with development of type 2 diabetes may be partly mediated by altered secretion of adipokines by adipose tissue. Greater adiposity down-regulates secretion of adiponectin, an adipokine with anti-inflammatory and insulin-sensitizing properties. The strength and consistency of the relation between plasma adiponectin and risk of type 2 diabetes is unclear. OBJECTIVE: To systematically review prospective studies of the association of plasma adiponectin levels and risk of type 2 diabetes. DATA SOURCES: A systematic search of the MEDLINE, EMBASE, and Science Citation Index Expanded databases using adiponectin and diabetes and various synonyms and reference lists of retrieved articles up to April 10, 2009. STUDY SELECTION: We included prospective studies with plasma adiponectin levels as the exposure and incidence of type 2 diabetes as the outcome variable. DATA EXTRACTION: Two reviewers independently extracted data and assessed study quality. Generalized least-squares trend estimation was used to assess dose-response relationships. Pooled relative risks and 95% confidence intervals were calculated using random-effects models to incorporate between-study variation. RESULTS: Thirteen prospective studies with a total of 14 598 participants and 2623 incident cases of type 2 diabetes were included in the meta-analysis. Higher adiponectin levels were monotonically associated with a lower risk of type 2 diabetes. The relative risk of type 2 diabetes was 0.72 (95% confidence interval, 0.67-0.78) per 1-log microg/mL increment in adiponectin levels. This inverse association was consistently observed in whites, East Asians, Asian Indians, African Americans, and Native Americans and did not differ by adiponectin assay, method of diabetes ascertainment, duration of follow-up, or proportion of women. The estimated absolute risk difference (cases per 1000 person-years) per 1-log microg/mL increment in adiponectin levels was 3.9 for elderly Americans and 30.8 for Americans with impaired glucose tolerance. CONCLUSION: Higher adiponectin levels are associated with a lower risk of type 2 diabetes across diverse populations, consistent with a dose-response relationship.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“reduced adiponectin concentrations are associated with increased inflammation and risks of diabetes and cardiovascular disease.”
From The Vasculature in Prediabetes (2018) · cites this paper as [97]
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824
Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis
Greenland, S., & Longnecker, M. P. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116237 · Cited by 2,353
Adipose tissue dysfunction in obesity, diabetes, and vascular diseases
Hajer, G. R., van Haeften, T. W., & Visseren, F. L. J. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn387 · Cited by 1,410
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 991
Jacobo‐Albavera, L., Posadas‐Romero, C., Vargas‐Alarcón, G., Romero‐Hidalgo, S., Posadas‐Sánchez, R., González-Salazar, M. D. C., Carnevale, A., Canizales‐Quinteros, S., Medina-Urrutia, A. X., Antúnez-Argüelles, E., et al. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0040-3 · Cited by 20
Serdan, T. D. A., Masi, L. N., Pereira, J. N. B., Rodrigues, L. E., Alecrim, A. L., Scervino, M. V. M., Diniz, V. L. S., dos Santos, A. A. C., Filho, C. P. B. S., Alba‐Loureiro, T. C., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112019 · Cited by 18
Serum and salivary adipokines in type 2 diabetes – Results of a pilot study in India
Vinitha, R., Yogalakshmi, R., Rajeswari, A., Snehalatha, C., Nair, D. R., Susairaj, P., Satheesh, K., Nanditha, A., Raghavan, A., Arun, K., et al. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102536 · Cited by 18
Wu, H., Yu, Z., Qi, Q., Li, H., Sun, Q., & Lin, X. (2011) · BMJ Open · doi:10.1136/bmjopen-2011-000191 · Cited by 18
Gruzdeva, O. V., Учасова, Е. Г., Dyleva, Y. A., Евгеньевна, А. О., Каретникова, В. Н., & Барбараш, О. Л. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00324 · Cited by 18
Kundel, V., Lehane, D., Ramachandran, S., Fayad, Z. A., Robson, P. M., Shah, N. A., & Mani, V. (2021) · Nature and Science of Sleep · doi:10.2147/nss.s327341 · Cited by 16
Queiroz, C. P., Vieira, M. S., Gonçalves-Pereira, M. H., de Almeida, S. S., Freire, R. H., Gomes, M. A., Alvarez-Leite, J. I., & Santiago, H. C. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010105 · Cited by 17
Pramanik, R., Dey, A., Chakrabarty, A. K., Banerjee, D., Narwaria, A., Sharma, S. K., Rai, R. K., Katiyar, C. K., & Dubey, S. K. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118402 · Cited by 18
Bansal, N., Anderson, S. G., Vyas, A., Gemmell, I., Charlton-Menys, V., Oldroyd, J. C., Pemberton, P. W., Durrington, P. N., Clayton, P., & Cruickshank, J. K. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0046 · Cited by 17
Nash, S. H., Kristal, A. R., Bersamin, A., Choy, K., Hopkins, S. E., Stanhope, K. L., Havel, P. J., Boyer, B. B., & O’Brien, D. M. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.230 · Cited by 17
Association of adiponectin levels and insulin demand in critically ill patients
Hillenbrand, A., Weiß, M., Hillenbrand, A., Knippschild, U., Wolf, A.-M., Henne‐Bruns, D., & Huber-Lang, M. S. (2011) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s15211 · Cited by 17
A Tangled Threesome: Adiponectin, Insulin Sensitivity, and Adiposity
Kizer, J. R. (2013) · Diabetes · doi:10.2337/db12-1673 · Cited by 17
Clinical Benefits of Pitavastatin: Focus On Patients With Diabetes Or at Risk of Developing Diabetes
Barrios, V., & Escobar, C. (2016) · Future Cardiology · doi:10.2217/fca-2016-0018 · Cited by 17
Abraham, P. A., Attipoe, S., Kazman, J. B., Zeno, S. A., Poth, M., & Deuster, P. A. (2017) · African Health Sciences · doi:10.4314/ahs.v17i1.13 · Cited by 17
Adipocytokine correlations with thyroid function and autoimmunity in euthyroid sardinians
Delitala, A., Steri, M., Fiorillo, E., Marongiu, M., Lakatta, E. G., Schlessinger, D., & Cucca, F. (2018) · Cytokine · doi:10.1016/j.cyto.2018.08.027 · Cited by 17
Okada‐Iwabu, M., Iwabu, M., Yamauchi, T., & Kadowaki, T. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0310 · Cited by 17
Noordam, R., Boersma, V., Verkouter, I., le Cessie, S., Christen, T., Lamb, H. J., Rosendaal, F. R., van Dijk, K. W., van Heemst, D., & de Mutsert, R. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.04.021 · Cited by 17
Bondor, C. I., Potra, A. R., Moldovan, D. T., Rusu, C. C., Ciorba-Pop, M., Mureșan, A., Vlăduțiu, D., & Kacsó, I. M. (2015) · International Urology and Nephrology · doi:10.1007/s11255-015-1004-2 · Cited by 17
Coltell, Ó., Ortega‐Azorín, C., Sorlí, J. V., Portolés, O., Asensio, E. M., Sáiz, C., Barragán, R., Estruch, R., & Corella, D. (2021) · Nutrients · doi:10.3390/nu13020541 · Cited by 19
Mazidi, M., Shekoohi, N., Katsiki, N., Rakowski, M., Mikhailidis, D. P., & Banach, M. (2021) · Archives of Medical Science · doi:10.5114/aoms/119965 · Cited by 17
Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women
Rodrigues, M. H., Bruno, A. D. S., Nahás-Neto, J., Santos, M. E. S. M., & Nahás, E. A. P. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2013.875992 · Cited by 17
The relationship between adiponectin, ageing and renal function in a bi-ethnic sample
Kruger, I. M., Huisman, H. W., & Schutte, A. E. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2011.04.003 · Cited by 17
Mohammadi, S. M., Eghbali, S. A., Soheilikhah, S., Ashkezari, S. J., Salami, M., Afkhami‐Ardekani, M., & Afkhami-Ardekani, A. (2016) · Electronic physician · doi:10.19082/2849 · Cited by 17
Khalafi, M., Maleki, A. H., Symonds, M. E., Alamdari, K. A., Ehsanifar, M., & Rosenkranz, S. K. (2025) · Obesity Reviews · doi:10.1111/obr.13954 · Cited by 18
Adiponectin and Atherosclerosis in Rheumatoid Arthritis
Dessein, P. H., Tsang, L., Solomon, A., Woodiwiss, A. J., Millen, A. M. E., & Norton, G. R. (2014) · Mediators of Inflammation · doi:10.1155/2014/358949 · Cited by 16
Akram, F., Gragnoli, C., Raheja, U. K., Snitker, S., Lowry, C. A., Stearns‐Yoder, K. A., Hoisington, A. J., Brenner, L. A., Saunders, E. F. H., Stiller, J. W., et al. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.12.016 · Cited by 16
Chen, H., Petty, L. E., North, K. E., McCormick, J. B., Fisher‐Hoch, S. P., Gamazon, E. R., & Below, J. E. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac039 · Cited by 16
Deischinger, C., Sluková, D., Just, I., Kaufmann, U., Harreiter, J., van Trotsenburg, M., Trattnig, S., Krššák, M., Kautzky‐Willer, A., Klepochová, R., et al. (2022) · International Journal of Transgender Health · doi:10.1080/26895269.2022.2123425 · Cited by 18
Mao, Y., & Zhong, W. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110700 · Cited by 16
Fujiwara, N., & Nakagawa, H. (2023) · Cancer Science · doi:10.1111/cas.15925 · Cited by 14
Vinitha, R., Jagannathan, R., Snehalatha, C., Nanditha, A., Shetty, A. S., Raghavan, A., Godsland, I. F., Johnston, D. G., & Ramachandran, A. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.035 · Cited by 16
Cardiovascular Risk in Children and Adolescents with Type 2 Diabetes Mellitus
Prendergast, C., & Gidding, S. S. (2014) · Current Diabetes Reports · doi:10.1007/s11892-013-0454-0 · Cited by 19
Serum Adiponectin and Type 2 Diabetes: A 6-Year Follow-Up Cohort Study
Jee, S. H., Ahn, C. W., Park, J. S., Park, C. G., Kim, H.-S., Lee, S., Park, S., Lee, M., Lee, C. B., Park, H. S., et al. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.4.252 · Cited by 16
The evolving role of adiponectin as an additive biomarker in HFrEF
Sente, T., Gevaert, A. B., Berendoncks, A. V., Vrints, C. J., & Hoymans, V. Y. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9578-z · Cited by 16
Hulgan, T., Ramsey, B. S., Koethe, J. R., Samuels, D. C., Gerschenson, M., Libutti, D. E., Sax, P. E., Daar, E. S., McComsey, G. A., & Brown, T. T. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001926 · Cited by 16
Guo, Y. J., Liu, L., & Wang, J. (2019) · Bioscience Reports · doi:10.1042/bsr20182284 · Cited by 16
Behan-Bush, R. M., Liszewski, J. N., Schrodt, M. V., Vats, B., Li, X., Lehmler, H., Klingelhutz, A. J., & Ankrum, J. A. (2023) · Environmental Science & Technology · doi:10.1021/acs.est.2c07281 · Cited by 18
MicroRNA-218 targets adiponectin receptor 2 to regulate adiponectin signaling
Du, H., Fu, Z., He, G., WANG, Y., Xia, G.-Y., FANG, M., & Zhang, T. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3282 · Cited by 16
Circulating biomarkers that predict incident dementia
Weinstein, G., & Seshadri, S. S. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt235 · Cited by 16
Adiponectin in chronic heart failure: influence of diabetes and genetic variants
Masson, S., Gori, F., Latini, R., Milani, V., Flyvbjerg, A., Frystyk, J., Crociati, L., Pietri, S. D., Vago, T., Barlera, S., et al. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02548.x · Cited by 16
Yıldız, Y., Özakşit, G., Ünlü, B. S., Özgü, E., Energin, H., Kaba, M., & Uğur, M. (2014) · Europe PMC (PubMed Central) · Cited by 16
Liang, B., Wang, X., Guo, X., Yang, Z., Bai, R., Liu, M., Xiao, C., & Bian, Y. (2015) · Europe PMC (PubMed Central) · Cited by 16
Serum adiponectin/Ferritin ratio in relation to the risk of type 2 diabetes and insulin sensitivity
Aregbesola, A., de Mello, V. D., Lindström, J., Voutilainen, S., Virtanen, J. K., Keinanen-Kiukaanniemi, S. M., Tuomainen, T., Tuomilehto, J. O., & Uusitupa, M. I. J. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.012 · Cited by 16
Unraveling the Pathogenesis of the Depression–Diabetes Link
Ismail, K. (2010) · Wiley eBooks · doi:10.1002/9780470667309.ch2 · Cited by 16
Vasamsetti, S. B., Sadaf, S., Uddin, M. A., Shen, J., Johny, E., Mondal, A., Florentin, J., Lei, L., Mannan, A., Rao, K. M. K., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69196-4 · Cited by 16
Pioglitazone Increases Whole Body Insulin Sensitivity in Obese, Insulin-Resistant Rhesus Monkeys
Tozzo, E., Bhat, G., Cheon, K., & Camacho, R. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126642 · Cited by 15
Paiman, E. H. M., de Mutsert, R., Widya, R. L., Rosendaal, F. R., Jukema, J. W., & Lamb, H. J. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.07.011 · Cited by 16
Majeed, M. A., Narayanan, N. K., Mundkur, L., Prakasan, P., & Nagabhushanam, K. (2023) · Nutraceuticals · doi:10.3390/nutraceuticals3030026 · Cited by 15
Decreased AdipoR1 signaling and its implications for obesity-induced male infertility
Kobori, T., Iwabu, M., Okada‐Iwabu, M., Ohuchi, N., Kikuchi, A., Yamauchi, N., Kadowaki, T., Yamauchi, T., & Kasuga, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-56290-0 · Cited by 15
Sam, S., Haffner, S. M., Davidson, M. H., D’Agostino, R. B., Pérez, A., & Mazzone, T. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1699 · Cited by 15
Emerging role of the GH/IGF-I on cardiometabolic control.
Oliveira, C. R. P., Meneguz‐Moreno, R. A., Aguiar-Oliveira, M. H., & Barreto‐Filho, J. A. (2011) · PubMed · doi:10.1590/s0066-782x2011001400012 · Cited by 11
Duncan, A. F., Frankfurt, J. A., Heyne, R. J., & Rosenfeld, C. R. (2017) · Pediatric Research · doi:10.1038/pr.2017.11 · Cited by 15
Relationships between adiponectin and bone: Sex difference
Bi, X., Loo, Y. T., & Henry, C. J. (2019) · Nutrition · doi:10.1016/j.nut.2019.04.004 · Cited by 17
Alfazema, N., Barrier, M., de Procé, S. M., Menzies, R. I., Carter, R., Stewart, K., Diaz, A. I. G., Moyon, B., Webster, Z., Bellamy, C. O. C., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12409 · Cited by 15
Anti-obesity effect of Yangkyuksanwha-tang in high-fat diet-induced obese mice
Koh, Y.-M., Jang, S.-W., & Ahn, T.-W. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2669-3 · Cited by 15
Sweeney, T. E., Ogunmoroti, O., Ndumele, C. E., Zhao, D., Varma, B., Allison, M., Budoff, M. J., Fashanu, O. E., Sharma, A., Bertoni, A. G., et al. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.11.002 · Cited by 15
Zyriax, B., Salazar, R., Hoeppner, W., Vettorazzi, E., Herder, C., & Windler, E. E. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075807 · Cited by 15
Obata, Y., Yamada, Y., Kyo, M., Takahi, Y., Saisho, K., Tamba, S., Yamamoto, K., Katsuragi, K., & Matsuzawa, Y. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12078 · Cited by 15
Ramachandran, R., Gravenstein, K. S., Metter, E. J., Egan, J. M., Ferrucci, L., & Chia, C. W. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03865.x · Cited by 16
Nirengi, S., Fujibayashi, M., Tsuzaki, K., Furuno, S., Uchibe, A., Kawase, Y., Kotani, K., & Sakane, N. (2016) · Endocrine Practice · doi:10.4158/ep15963.or · Cited by 15
Retnakaran, R. R., Ye, C., Connelly, P. W., Hanley, A. J., Sermer, M., & Zinman, B. (2017) · Diabetes Care · doi:10.2337/dc17-0781 · Cited by 15
Canivell, S., Ruano, E. G., Sisó‐Almirall, A., Kostov, B., Paz, L. G., Fernández‐Rebollo, E., Hanzu, F. A., Párrizas, M., Novials, A., & Gomis, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075474 · Cited by 16
The effect of 25-hydroxyvitamin D on insulin sensitivity in obesity: is it mediated via adiponectin?
Wright, O. R. L., Hickman, I. J., Petchey, W. G., Sullivan, C. M., Ong, C. R., Rose, F. J., Ng, C., Prins, J. B., Whitehead, J. P., & O'Moore‐Sullivan, T. M. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0436 · Cited by 15
Type 2 diabetes mellitus risk and exercise: is resistin involved?
Cobbold, C. (2019) · The Journal of Sports Medicine and Physical Fitness · doi:10.23736/s0022-4707.18.08258-0 · Cited by 22
Christen, T., de Mutsert, R., Lamb, H. J., van Dijk, K. W., le Cessie, S., Rosendaal, F. R., Jukema, J. W., & Trompet, S. (2021) · Peptides · doi:10.1016/j.peptides.2021.170664 · Cited by 14
Adipocyte-hepatocyte crosstalk in cellular models of obesity: Role of soluble factors
Baldini, F., Diab, F., Serale, N., Zeaiter, L. Z., Portincasa, P., Diaspro, A., & Vergani, L. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121464 · Cited by 15
Relationship Between Obesity and Depression Considering the Inflammatory Theory
Oracz, A. J., Zwierz, M., Naumowicz, M., Suprunowicz, M., & Waszkiewicz, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26114966 · Cited by 20
Schootman, M., Andresen, E. M., Wolinsky, F. D., Malmstrom, T. K., Morley, J. E., & Miller, D. K. (2010) · Journal of Urban Health · doi:10.1007/s11524-009-9426-8 · Cited by 14
Serum adiponectin concentration in relation to macronutrient and food intake in young Japanese women
Murakami, K., Sasaki, S., & Uenishi, K. (2013) · Nutrition · doi:10.1016/j.nut.2013.04.012 · Cited by 14
de Luis, D. A., Izaola, O., de la Fuente, B., & Aller, R. (2014) · PubMed · doi:10.3305/nh.2014.30.4.7864 · Cited by 14
Ko, J. K. Y., Li, R., Lam, K. S. L., Tam, S., Lee, V. C. Y., Yeung, T. W. Y., Ho, P. C., & Ng, E. H. Y. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1126708 · Cited by 14
Babińska, A., Kaszubowski, M. F., Kmieć, P., & Sworczak, K. (2018) · Steroids · doi:10.1016/j.steroids.2018.08.011 · Cited by 14
Plasma adiponectin is associated with less atherogenic lipoprotein phenotype
Shin, M., & Kim, O. Y. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.01.014 · Cited by 14
Kawada, T., & Hasegawa, M. (2012) · Annals of Human Biology · doi:10.3109/03014460.2011.652170 · Cited by 14
Relationship between Birth Weight and Metabolic Status in Obese Adolescents
Hill, D. J., Harry Prapavessis, A., Shoemaker, J. K., Jackman, M., Mahmud, F. H., & Clarson, C. L. (2013) · ISRN Obesity · doi:10.1155/2013/490923 · Cited by 14
Spirulina Reverses Histomorphological Changes in Diabetic Osteoporosis in Pioglitazone Treated Rats
Devesh, C. (2012) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s1-006 · Cited by 14
Nogueira, L., Newton, C. C., Pollak, M., Silverman, D. T., Albanes, D., Männistö, S., Weinstein, S. J., Jacobs, E. J., & Stolzenberg‐Solomon, R. Z. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0891 · Cited by 15
Brännmark, C., Lövfors, W., Komai, A. M., Axelsson, T., Hachmane, M. F. E., Musovic, S., Paul, A., Nyman, E., & Olofsson, C. S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.801225 · Cited by 14
Clues from Bariatric Surgery: Reversing Insulin Resistance to Heal the Heart
Khalaf, K. I., & Taegtmeyer, H. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0364-1 · Cited by 13
Pan, J., Ding, Y., Sun, Y., Li, Q., Wei, T., Gu, Y., Zhou, Y., Pang, N., Pei, L., Ma, S., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062126 · Cited by 13
Sasaki, T., Nishimoto, Y., Hirata, T., Abe, Y., Hirose, N., Takayama, M., Takebayashi, T., Okano, H., & Arai, Y. (2023) · eLife · doi:10.7554/elife.86309 · Cited by 13
Fajkić, A., Jahić, R., Ejubović, M., Đešević, M., Ejubović, A. J., & Lepara, O. (2024) · Medicina · doi:10.3390/medicina60111795 · Cited by 15
Klein, L., Lenz, C., Krüger, K., Lorkowski, S., Kipp, K., & Dawczynski, C. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02517-6 · Cited by 14
Chang, M., Yeh, H.-C., Tsou, Y., Wang, C., Cheng, H., Sung, C., Ho, Y., Chen, T., & Yeh, C. (2012) · Obesity · doi:10.1038/oby.2012.45 · Cited by 13
Haugen, S., He, J., Sundaresan, A., Stunes, A. K., Aasarød, K. M., Tiainen, H., Syversen, U., Skallerud, B., & Reseland, J. E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00236 · Cited by 13
Semnani‐Azad, Z., Connelly, P. W., Johnston, L., Retnakaran, R. R., Harris, S. B., Zinman, B., & Hanley, A. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz166 · Cited by 13
An, S., Yu, J., Choi, H., Ko, H., Ahn, S., Shin, J. C., Pyo, J. J., Jeong, L. S., & Noh, M. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115226 · Cited by 13
Adiponectin is secreted via caveolin 1-dependent mechanisms in white adipocytes
Brännmark, C., Kay, E. I., Kugelberg, U. Ö., Chanclón, B., Shrestha, M. M., Asterholm, I. W., Strålfors, P., & Olofsson, C. S. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0078 · Cited by 13
Hakim, O., Bello, O., Ladwa, M., Peacock, J. L., Umpleby, A. M., Charles‐Edwards, G., Amiel, S. A., & Goff, L. M. (2020) · Nutrients · doi:10.3390/nu12123796 · Cited by 13
Gong, X., You, L., Li, F., Chen, Q., Chen, C., Zhang, X., Zhang, X., Xuan, W., Sun, K., Lao, G., et al. (2021) · Endocrine Connections · doi:10.1530/ec-21-0235 · Cited by 13
Dose-dependent effects of atorvastatin on myocardial infarction
Учасова, Е. Г., Барбараш, О. Л., Gruzdeva, O. V., Belik, E. V., Dyleva, Y. A., & Каретникова, В. Н. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s86344 · Cited by 13
C‐reactive protein and incidence of type 2 diabetes in the Pizarra study
Rubio‐Martín, E., Soriguer, F., Gutiérrez‐Repiso, C., Garrido‐Sánchez, L., de Adana, M. R., García‐Fuentes, E., Morcillo, S., Esteva, I., Chaves, F. J., & Rojo‐Martínez, G. (2012) · European Journal of Clinical Investigation · doi:10.1111/eci.12027 · Cited by 14
Phosphodiesterase 5 as target for adipose tissue disorders
Colombo, G., Colombo, M. D. H. P., Schiavon, L. D. L., & d'Acâmpora, A. J. (2013) · Nitric Oxide · doi:10.1016/j.niox.2013.10.006 · Cited by 13
Longitudinal Analysis of Adiponectin through 20-Year Type 1 Diabetes Duration
LeCaire, T. J., & Palta, M. (2015) · Journal of Diabetes Research · doi:10.1155/2015/730407 · Cited by 13
A Novel Role of Globular Adiponectin in Treatment with HFD/STZ Induced T2DM Combined with NAFLD Rats
Ma, H., You, G.-P., Zhang, X.-P., Yang, X.-J., Lu, H., Huang, Y., & Zhang, W. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/230835 · Cited by 12
Zhou, Y., Zhang, J., Zhang, W., & Ni, Z. (2016) · Journal of Research in Medical Sciences · doi:10.4103/1735-1995.184000 · Cited by 13
Gala, T. D. L. H., Herder, C., Rutters, F., Carstensen‐Kirberg, M., Huth, C., Stehouwer, C. D. A., Nijpels, G., Schalkwijk, C. G., Flyvbjerg, A., Franks, P. W., et al. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3063 · Cited by 13
Moreira, M. E. D. C., Araújo, F. D. O., de Sousa, A. R., Toledo, R. C. L., Benjamin, L. D. A., Veloso, M. P., Reis, K. D. S., dos Santos, M. H., & Martino, H. S. D. (2018) · Food Research International · doi:10.1016/j.foodres.2018.08.004 · Cited by 13
Wang, Y., Koh, W., Sim, X., Yuan, J., & Pan, A. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0020 · Cited by 14
Metadata
- Authors
- Li, S., Shin, H. J., Ding, E. L., & van Dam, R. M.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2009-07-08
- Volume
- 302
- Issue
- 2
- Pages
- 179
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2041272089
- Cited by
- 991
- References
- 43
- Citations by year
- 2026: 16 · 2025: 37 · 2024: 48 · 2023: 47 · 2022: 44 · 2021: 43 · 2020: 58 · 2019: 50 · 2018: 60 · 2017: 51 · 2016: 62 · 2015: 77 · 2014: 89 · 2013: 89 · 2012: 82
- FWCI
- 49.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK4600)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- adiponectin, type 2 diabetes, plasma adiponectin levels, adipokines, obesity, insulin sensitivity, anti-inflammatory activity, dose-response relationship, impaired glucose tolerance, ethnic differences, diabetes risk
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Risk Factors, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review